First Trust Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-221,626
| Closed | -$718K | – | 2557 |
|
|
2024
Q3 | $718K | Buy |
221,626
+82,529
| +59% | +$267K | ﹤0.01% | 2093 |
|
|
2024
Q2 | $264K | Sell |
139,097
-31,381
| -18% | -$59.6K | ﹤0.01% | 2223 |
|
|
2024
Q1 | $484K | Buy |
170,478
+153,098
| +881% | +$435K | ﹤0.01% | 2157 |
|
|
2023
Q4 | $256K | Buy |
+17,380
| New | +$256K | ﹤0.01% | 2260 |
|
|
2023
Q3 | – | Sell |
-54,115
| Closed | -$1.17M | – | 2348 |
|
|
2023
Q2 | $1.17M | Buy |
54,115
+26,798
| +98% | +$578K | ﹤0.01% | 1936 |
|
|
2023
Q1 | $801K | Sell |
27,317
-29,503
| -52% | -$866K | ﹤0.01% | 2023 |
|
|
2022
Q4 | $2.1M | Buy |
+56,820
| New | +$2.1M | ﹤0.01% | 1677 |
|